Copyright
©The Author(s) 2019.
World J Clin Cases. Oct 26, 2019; 7(20): 3185-3193
Published online Oct 26, 2019. doi: 10.12998/wjcc.v7.i20.3185
Published online Oct 26, 2019. doi: 10.12998/wjcc.v7.i20.3185
Table 1 Baseline demographic data of patients in the robotic radical hysterectomy and laparoscopic radical hysterectomy groups
RRH (n = 216) | LRH (n = 342) | P value | |
Age (yr) | 48.90 ± 9.65 | 47.49 ± 9.81 | 0.773 |
BMI (kg/m2) | 24.20 ± 3.37 | 23.74 ± 2.96 | 0.925 |
FIGO stage | |||
IA1-IB1 | 133 (61.57%) | 208 (60.82%) | |
IB2-IIA1 | 67 (35.65%) | 105 (30.70%) | 0.902 |
IIA2-IIB | 16 (2.78%) | 29 (8.48%) | |
Pathological type | |||
Squamous cell carcinoma | 196 (90.74%) | 316 (92.40%) | |
Adenocarcinoma | 19 (8.80%) | 22 (6.43%) | 0.504 |
Adenosquamous carcinoma | 1 (0.46%) | 2 (0.58%) |
Table 2 Operative and postoperative adjuvant treatment parameters in the robotic radical hysterectomy and laparoscopic radical hysterectomy groups
LRH (n = 342) | RRH (n = 216) | P value | |
Operative time (min) | 233.50 ± 59.76 | 197.16 ± 57.76 | 0.001 |
Intraoperative blood loss (mL) | 280.74 ± 246.66 | 163.09 ± 320.95 | 0.001 |
Intraoperative blood vessel and organ injuries (cases) | 3 (0.87%) | 5 (2.31%) | 0.153 |
Total number of dissected lymph nodes (pieces) | 25.09 ± 11.41 | 23.51 ± 9.31 | 0.748 |
Intraoperative blood transfusion (cases) | 39 (11.57%) | 8 (3.80%) | 0.001 |
Total length of hospital stay (d) | 17.19 ± 6.29 | 18.57 ± 5.61 | 0.777 |
Length of postoperative hospital stay (d) | 10.87 ± 4.44 | 12.28 ± 5.06 | 0.772 |
Postoperative chemotherapy (cases) | 172 (50.29%) | 102 (47.22%) | 0.268 |
Postoperative radiotherapy (cases) | 42 (12.28%) | 25 (11.57%) | 0.457 |
Table 3 Postoperative complications in the robotic radical hysterectomy and laparoscopic radical hysterectomy groups, n (%)
RRH (n = 216) | LRH (n = 342) | P value | |
Total complications (cases) | 20 (9.65) | 60 (17.59) | 0.012 |
Early postoperative complications (within 4 wk) | |||
Infection (cases) | 3 (1.46) | 12 (3.70) | 0.007 |
Fever (including infection with fever) (cases) | 9 (4.39) | 22 (6.48) | 0.017 |
Venous thrombosis (cases) | 1 (0.46) | 0 (0) | 0.387 |
Other | 1 (0.46) | 2 (0.58) | 0.667 |
Long-term postoperative complications (after 4 wk) | |||
Lower extremity edema | 8 (3.80) | 16 (4.63) | 0.036 |
Inguinal lymphatic cyst | 3 (1.39) | 3 (0.88) | 0.429 |
Other | 1 (0.46) | 0 (0) | 0.387 |
Table 4 Follow-up data in the robotic radical hysterectomy and laparoscopic radical hysterectomy groups
RRH(n = 216) | LRH (n = 342) | P value | |
Average follow-up period (mo) | 30.07 ± 15.67 | 29.48 ± 15.07 | 0.658 |
Median follow-up period (mo) | 29.0 (1.0-58.0) | 30.0 (3.0-58.0) | |
Recurrence | |||
Total recurrence rate | 15.7% | 12.00% | 0.206 |
Number of patients with recurrence | 34 | 41 | |
Median recurrence time (mo) | 20.0 (7.0-49.0) | 20.0 (3.0-48.0) | |
Survival | |||
Progression-free survival rate | 81.02% | 85.67% | 0.157 |
Progression-free survival time | 28.91 ± 15.68 | 28.34 ± 15.13 | 0.669 |
Overall survival rate | 92.13% | 94.45% | 0.292 |
Overall survival time | 29.87 ± 15.92 | 29.41 ± 15.14 | 0.732 |
- Citation: Chen L, Liu LP, Wen N, Qiao X, Meng YG. Comparative analysis of robotic vs laparoscopic radical hysterectomy for cervical cancer. World J Clin Cases 2019; 7(20): 3185-3193
- URL: https://www.wjgnet.com/2307-8960/full/v7/i20/3185.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i20.3185